首页> 外文期刊>Caries research >Susceptibility of Streptococcus mutans and Streptococcus sobrinus to Cell Wall Inhibitors and Development of a Novel Selective Medium for S. sobrinus.
【24h】

Susceptibility of Streptococcus mutans and Streptococcus sobrinus to Cell Wall Inhibitors and Development of a Novel Selective Medium for S. sobrinus.

机译:变形链球菌和sobrinus链球菌对细胞壁抑制剂的敏感性和新型sobrinus选择性培养基的开发。

获取原文
获取原文并翻译 | 示例
           

摘要

Representative strains of Streptococcus mutans and Streptococcus sobrinus showed differences in susceptibility to members of the monobactam group of beta-lactam antibiotics: S. sobrinus was less sensitive than S. mutans. The minimum inhibitory concentrations of aztreonam (AZT) and carumonam, both of which belong to this group, were 2,000 &mgr;g/ml for S. sobrinus and 125 &mgr;g/ml for S. mutans. Further addition of fosfomycin, bacitracin and sodium chloride to Mitis Salivarius agar (MS) supplemented with AZT resulted in growth inhibition of S. mutans and oral streptococci other than S. sobrinus, and was therefore used as a selective medium for S. sobrinus (MS-SOB medium). The average growth recovery of laboratory and clinically isolated strains of S. sobrinus on MS-SOB medium was 74.1% compared to that on MS medium. Seventy-eight percent of clinical samples in which S. sobrinus was detected yielded pure growth of S. sobrinus on MS-SOB medium. Copyright 2002 S. Karger AG, Basel
机译:变形链球菌和链球菌的代表性菌株显示出对β-内酰胺类抗生素的单bactam组成员的易感性差异:链球菌不如变形链球菌。均属于该组的氨曲南(AZT)和卡鲁莫南的最低抑菌浓度分别为sobrinus和变形链球菌分别为2,000 mg / ml和125 mg / ml。向补充了AZT的唾液琼脂(MS)中进一步添加磷霉素,杆菌肽和氯化钠会导致变形链球菌和除链球菌之外的口服链球菌的生长受到抑制,因此被用作针对链球菌(MS)的选择性培养基-SOB媒体)。与MS培养基相比,实验室和临床分离的链球菌菌株在MS-SOB培养基上的平均生长恢复率为74.1%。在MS-SOB培养基上,检测到链球菌的临床样品中有78%产生了链球菌的纯生长。版权所有2002 S. Karger AG,巴塞尔

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号